Ibandronate sodium

Modify Date: 2024-01-02 12:16:19

Ibandronate sodium Structure
Ibandronate sodium structure
Common Name Ibandronate sodium
CAS Number 138926-19-9 Molecular Weight 359.226
Density N/A Boiling Point 587.8ºC at 760 mmHg
Molecular Formula C9H24NNaO8P2 Melting Point 84ºC (dec)
MSDS N/A Flash Point 309.3ºC

 Use of Ibandronate sodium


Ibandronate is a highly potent nitrogen-containing bisphosphonate used for the treatment of osteoporosis.Target: OthersIbandronate (1.25-2 μM) significantly reduces endothelial cell growth, while ibandronate (2 μM) also significantly reduces capillary-like tube formation and increases apoptosis of endothelial cells. Ibandronate (< 100 μM) dose-dependently increases VEGF expression in endothelial cells [1]. Ibandronate (< 100 μM) inhibits growth of both prostate cancer cell lines (LNCaP and PC-3) in a dose dependent manner [2].Ibandronate administered either daily (2.5 mg) or intermittently (20 mg every other day for 12 doses every 3 months) significantly reduces the risk of new morphometric vertebral fractures by 62% and 50% (p = 0.0006), respectively, in osteoporotic women after 3 years' treatment. Ibandronate administered either daily (2.5 mg) or intermittently (20 mg every other day for 12 doses every 3 months) significantly and progressively increases BMD of lumbar spine by 6.5% and 5.7%, respectively, in osteoporotic women after 3 years' treatment [3]. Ibandronate (< 125 mg/kg s.c.) results in a dose dependent increase in bone mineral density (BMD), trabecular bone volume and trabecular number, load to failure (Fmax), and yield load in long bones and vertebrae in ovariectomized rats, and increased trabecular separation in ovariectomized rats is fully prevented by all doses [4].

 Names

Name Ibandronate Sodium Monohydrate
Synonym More Synonyms

 Ibandronate sodium Biological Activity

Description Ibandronate is a highly potent nitrogen-containing bisphosphonate used for the treatment of osteoporosis.Target: OthersIbandronate (1.25-2 μM) significantly reduces endothelial cell growth, while ibandronate (2 μM) also significantly reduces capillary-like tube formation and increases apoptosis of endothelial cells. Ibandronate (< 100 μM) dose-dependently increases VEGF expression in endothelial cells [1]. Ibandronate (< 100 μM) inhibits growth of both prostate cancer cell lines (LNCaP and PC-3) in a dose dependent manner [2].Ibandronate administered either daily (2.5 mg) or intermittently (20 mg every other day for 12 doses every 3 months) significantly reduces the risk of new morphometric vertebral fractures by 62% and 50% (p = 0.0006), respectively, in osteoporotic women after 3 years' treatment. Ibandronate administered either daily (2.5 mg) or intermittently (20 mg every other day for 12 doses every 3 months) significantly and progressively increases BMD of lumbar spine by 6.5% and 5.7%, respectively, in osteoporotic women after 3 years' treatment [3]. Ibandronate (< 125 mg/kg s.c.) results in a dose dependent increase in bone mineral density (BMD), trabecular bone volume and trabecular number, load to failure (Fmax), and yield load in long bones and vertebrae in ovariectomized rats, and increased trabecular separation in ovariectomized rats is fully prevented by all doses [4].
Related Catalog
References

[1]. Morgan, C., S. Jeremiah, and J. Wagstaff, Metronomic administration of ibandronate and its anti-angiogenic effects in vitro. Microvasc Res, 2009. 78(3): p. 453-8.

[2]. Epplen, R., et al., Differential effects of ibandronate, docetaxel and farnesol treatment alone and in combination on the growth of prostate cancer cell lines. Acta Oncol, 2011. 50(1): p. 127-33.

[3]. Chesnut, I.C., et al., Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J Bone Miner Res, 2004. 19(8): p. 1241-9.

[4]. Bauss, F., et al., Effects of treatment with ibandronate on bone mass, architecture, biomechanical properties, and bone concentration of ibandronate in ovariectomized aged rats. J Rheumatol, 2002. 29(10): p. 2200-8.

 Chemical & Physical Properties

Boiling Point 587.8ºC at 760 mmHg
Melting Point 84ºC (dec)
Molecular Formula C9H24NNaO8P2
Molecular Weight 359.226
Flash Point 309.3ºC
Exact Mass 359.087494
PSA 170.21000
LogP 0.87390
Vapour Pressure 2.88E-16mmHg at 25°C
Storage condition -20°C Freezer

 Safety Information

Hazard Codes Xn: Harmful;
Risk Phrases R40
Safety Phrases 22-36
RIDADR UN 1759 8 / PGIII
HS Code 2922199090

 Synthetic Route

~%

Ibandronate sodium Structure

Ibandronate sodium

CAS#:138926-19-9

Literature: WO2005/63779 A2, ; Page/Page column 6 ;

~%

Ibandronate sodium Structure

Ibandronate sodium

CAS#:138926-19-9

Literature: WO2011/16738 A1, ; Page/Page column 9-10 ;

~%

Ibandronate sodium Structure

Ibandronate sodium

CAS#:138926-19-9

Literature: WO2008/60609 A1, ; Page/Page column 21 ;

~%

Ibandronate sodium Structure

Ibandronate sodium

CAS#:138926-19-9

Literature: WO2008/14510 A2, ; Page/Page column 24-25 ;

~%

Ibandronate sodium Structure

Ibandronate sodium

CAS#:138926-19-9

Literature: WO2008/60609 A1, ; Page/Page column 21 ;

~%

Ibandronate sodium Structure

Ibandronate sodium

CAS#:138926-19-9

Literature: WO2008/60609 A1, ; Page/Page column 22 ;

 Customs

HS Code 2922199090
Summary 2922199090. other amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%

 Synonyms

BM-21.0955 monosodium salt monohydrate
Sodium trihydrogen (1-hydroxy-3-(methylpentylamino)propylidene)diphosphonate, monohydrate.
Phosphonic acid, [1-hydroxy-3-(methylpentylamino)propylidene]bis-, sodium salt, hydrate (1:1:1)
Ibandronic acid monosodium salt monohydrate
Ibandronate sodium hydrate
Ibandronate sodium monohydrate
sodium,hydroxy-[1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl]phosphinate,hydrate
BM 21.0955Na.H2O
(1-​Hydroxy-​3-​(methylpentylamino)​propylidene)​bisphosphonic acid sodium
Sodium hydrogen {1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl}phosphonate hydrate (1:1:1)
Phosphonic acid, (1-hydroxy-3-(methylpentylamino)propylidene)bis-, monosodium salt, monohydrate
MFCD00912167
Ibandronate (Sodium Monohydrate)
Top Suppliers:I want be here





Get all suppliers and price by the below link:

Ibandronate sodium suppliers


Price: $158/10mM*1mLinWater

Reference only. check more Ibandronate sodium price